Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 82.50
-1.00 (-1.20%)
Oct 30, 2026, 1:30 PM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 12.22 billion as of October 30, 2026. It is the 16,401st most valuable company in the world and the 616th biggest in Taiwan. Its market cap has decreased by 33.47% in one year.
Market Cap
12.22B
Enterprise Value
10.07B
Revenue
10.12B
Global Rank
Country Rank
#616 Taiwan
PE Ratio
10.73
ChartMarket Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 12.22B, an increase of 426.21%. That is a compound annual growth rate of 4.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 12.22B | -34.78% |
| Dec 31, 2025 | 18.74B | -15.38% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 23.22B |
| Handa Pharmaceuticals | 22.35B |
| TTY Biopharm Company | 19.99B |
| YungShin Global Holding | 15.93B |
| ScinoPharm Taiwan | 15.74B |
| Synmosa Biopharma | 15.67B |
| Foresee Pharmaceuticals | 11.94B |
| Standard Chemical & Pharmaceutical | 10.17B |